Department of Molecular Oncology
BC Cancer, part of the Provincial Health Services Authority
  • Home
  • About
    • People
    • Location
    • Contact Us
  • Aparicio Lab
    • Personnel
    • Research
    • Datasets
  • Benard Lab
    • Personnel
    • Research
  • Huntsman Lab
    • Research
  • Lin Lab
    • Personnel
    • Research
  • Schrader Lab
    • Personnel
  • Shah Lab
    • Personnel
    • Research
  • Sorensen Lab
    • Personnel
    • Research
  • Platforms
    • Bimolecular fluorescence complementation (BiFC)
    • Breast Tumour Bank
    • Computational Biology
    • High-content Genetic Screens
    • Next Generation Sequencing
    • Tissue Microarrays
  • News
  • Careers
» Home » UBC

UBC

Dr. Samuel Aparicio named co-lead of new Stand Up to Cancer Canada – Canadian Breast Cancer Foundation Dream Team

Dr. Samuel Aparicio named co-lead of new Stand Up to Cancer Canada – Canadian Breast Cancer Foundation Dream Team

October 1, 2015

Dr. Samuel Aparicio named co-lead of new Stand Up to Cancer Canada – Canadian Breast Cancer Foundation Dream Team By: Jenn Currie, Communications Officer, BC Cancer Agency published on: 10/1/2015 Congratulations to our very own Dr. Samuel Aparicio who was recently named co-lead of the Stand Up to Cancer Canada—Canadian Breast Cancer Foundation Dream Team! […]

Posted in Aparicio Lab, News And Events, Research Funding | Tagged with Aparicio, BCCRC, SU2C, UBC

Significant childhood cancer discovery made by scientists at the BC Cancer Agency

May 11, 2015

Research published today by scientists at the BC Cancer Agency in Cancer Cell brings new hope for the treatment of high-risk childhood sarcomas – a type of cancer that has seen almost no treatment improvement in the last 20 years in spite of intense research efforts. Sarcomas are malignant – meaning they are cancerous – […]

Posted in Media, News And Events, Papers, Sorensen Lab | Tagged with BC Cancer Agency, BC Cancer Foundation, BCCRC, Cancer Cell, Cancer Research, Childhood cancers, Sarcoma, Sorensen, UBC

Dr. Francois Benard and TRIUMF team win NSERC Brockhouse Prize

February 17, 2015

NSERC Brockhouse Prize For CycloMed99 17 February 2015 For their outstanding teamwork in realizing a solution for safe and reliable isotope production for hospitals in Canada, interdisciplinary research team CycloMed99 will be receiving a prestigious national award at a ceremony in Ottawa today. The Honourable David Johnston, Governor General of Canada, will present the NSERC Brockhouse Canada […]

Posted in Benard Lab, Media, News And Events | Tagged with BC Cancer Agency, BCCA, BCCRC, Benard, Brockhouse Prize, Cancer Research, Cyclotron, Francois Benard, Media, Medical Isotopes, NSERC, Radiology, Research, TRIUMF, UBC

BC Cancer Agency scientists make internationally significant discovery, mapping the evolution of breast cancer ‘avatars’

BC Cancer Agency scientists make internationally significant discovery, mapping the evolution of breast cancer ‘avatars’

December 1, 2014

Vancouver – A just-published paper in the prestigious journal Nature highlights how researchers at the BC Cancer Agency are using human breast cancer ‘avatars’ — models of human breast cancers — to measure how complex cancers develop and change over time. The research is unprecedented because it uses single cancer cells to expose how breast […]

Posted in Aparicio Lab, Media, News And Events, Papers, Shah Lab | Tagged with Aparicio, BC Cancer Agency, BC Cancer Foundation, Cancer, Cancer Research, Nature, Shah, UBC, Xenografts

Dr. Samuel Aparicio named 2014 Aubrey J. Tingle Prize winner

November 10, 2014

Dr. Samuel Aparicio, 2014 Aubrey J. Tingle Prize recipient (photo: CNW Group/Canadian Cancer Society (National Office)) Breast cancer researcher Dr. Samuel Aparicio has been named the winner of the fifth annual Aubrey J. Tingle Prize. Created in honour of MSFHR’s founding president & CEO, this award is given to a British Columbia researcher whose work […]

Posted in Aparicio Lab, Media, News And Events | Tagged with Aubrey J Tingle Prize, BC Cancer Agency, Breast Cancer, Samuel Aparicio, UBC

Vancouver cancer researchers now key players on ‘dream team’

April 11, 2013

From the Vancouver Province By Mike Raptis The Province April 7, 2013 A group of Vancouver researchers will be playing a central role in a newly-formed international “pediatric cancer dream team.” The announcement came Sunday during the 2013 annual meeting of the St. Baldrick’s Foundation at the American Association for Cancer Research in Washington, D.C. The […]

Posted in Media, News And Events, Sorensen Lab | Tagged with BCCRC, Dream Team, Media, Pediatric Cancer, Research, Sorensen, The Province, UBC

Molecular Oncology Researchers Receive $1.25M Grant from the Canadian Cancer Society

February 26, 2013

Outsmarting breast cancer, one cell at a time With a $1.25 million grant from the Canadian Cancer Society, Dr Sam Aparicio and his team will answer questions about how breast cancer arises, grows and mutates. The researchers will use sophisticated techniques to analyze DNA from individual breast cancer cells and then observe how the cells […]

Posted in Aparicio Lab, Media, News And Events, Research Funding, Shah Lab | Tagged with Aparicio, BCCRC, CCSRI, Impact Grant, Shah, UBC

Department of Molecular Oncology researchers identify a genetic link between several rare cancers

December 28, 2011

Dr. David Huntsman and colleagues, including Drs. Aparicio, Sorensen and Shah, have identified mutations in a gene called DICER in rare, seemingly unrelated ovarian, uterine, and testicular cancers. When the group began sequencing the genomes of these and other rare tumours, they expected to find different gene mutations in each form of the disease. However, […]

Posted in Aparicio Lab, Media, News And Events, Papers, Shah Lab, Sorensen Lab | Tagged with Aparicio, BCCF, BCCRC, Cancer, CIHR, Genome BC, GSC, Huntsman, Morin, MSFHR, NEJM, Research, Shah, Sorensen, UBC

Department of Molecular Oncology scientist to tackle medical isotopes problem

November 28, 2009

The world is facing a shortage of the key medical isotope Technetium-99m (Tc-99m). More than 80% of the estimated 1.5 million nuclear medicine procedures performed annually in Canada use radiopharmaceuticals based on this isotope, which is currently produced using nuclear reactors. Together with TRIUMF and other partners, the BC Cancer Agency (BCCA) has received a […]

Posted in Benard Lab, News And Events | Tagged with BCCA, BCCRC, Benard, Research, TRIUMF, UBC

Recent Posts

  • Graduate Student Position at the BC Cancer Research Centre, Vancouver, Canada
  • Post-doctoral Fellow – Aparicio Lab
  • Research Assistant / Tech 3 Position
  • Research Animal Technician 2 – Benard Lab

RSS Pubmed Feed – Molecular Oncology

  • Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial.
Tweets by @bccancer_molonc